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Abstract
Background.Earlytechniquefailurehasbeenamajorlimi-
tationonthewideradoptionofperitonealdialysis(PD).The
objectives ofthis studyweretousedata fromalarge, multi-
centre, prospective database, the United Kingdom Renal
Registry (UKRR), in order to determine the ability of an
artificial neural network (ANN) model to predict early PD
technique failure and to compare its performance with a
logistic regression (LR)-based approach.
Methods.TheanalysisincludedallincidentPDpatientsen-
rolledintheUKRRfrom1999to2004.Theeventofinterest
was technique failure. For both the ANN and LR analyses
a bootstrap approach was used: the data were divided into
20 random training (75%) and validation (25%) sets. Mod-
els were derived on the latter and then used to make pre-
dictions on the former. Predictive accuracy was assessed
by area under the ROC curve (AUROC). The 20 AUROC
values and their standard errors were then averaged.
Results. There were 3269 patients included in the analy-
sis with a mean age of 59.9 years and a mean observa-
tion time of 430 days. Of the patients, 38.3% were female
and 90.8% were Caucasian. 1458 patients (44.6%) suffered
technique failure. The AUROC for the ANN model was
0.760 ± 0.0167 and the LR model was 0.709 and 0.0208.
(P = 0.0164)
Conclusions. Using UKRR data, both ANN and LR mod-
els predicted early PD technique failure with moderate ac-
curacy. In this study, an ANN outperformed an LR-based
approach. As the scope and the completeness of the UKRR
increases, thequestion of whether more sophisticated ANN
models will perform even better remains for further study.
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failure; logistic regression; peritoneal dialysis; technique
survival
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Introduction
End-stage renal disease (ESRD) prevalence continues to
rise worldwide [1]. Peritoneal dialysis (PD) is a clinically
and economically attractive mode of therapy for ESRD [2].
The survival of patients treated with PD is equivalent to
those who receive haemodialysis and PD has been associ-
ated with a greater self-reported quality of life [3,4]. Most
patientshavenomedicalcontraindicationstoeitherhaemo-
or peritoneal dialysis and are free to choose a modality on
the basis of social and logistical considerations [5]. Despite
the advantages of PD, the proportion of the ESRD popu-
lation who have adopted this modality is declining in both
EuropeandNorthAmerica[1,6].Thedecreaseinthepreva-
lence of PD patients may be due to the emergence of fac-
tors that limit its adoption. For example, as the median age
and degree of co-morbid illness increase among incident
ESRD patients, the fraction of patients with significant so-
cial and/or logistical barriers to PD adoption also increases
[7]. Early technique failure is another major constraint on
the growth of PD as a treatment option. Technique failure
necessitates a switch to haemodialysis that increases costs
and decreases patient self-reliance and social flexibility.
Factors affecting technique survival in PD have been
studied using single centre and registry data [8–12]. These
studies have used regression methods to determine the rel-
ative importance of a variety of factors on the risk of early
technique failure in groups of patients. Models that com-
bine these factors in order to predict early PD technique
failure for individual patients are lacking in the literature.
An accurate prediction model would be a potentially use-
ful way of identifying patients at particularly high risk of
early technique failure so that increased clinical scrutiny
and timely intervention could be brought to bear. Yet, pre-
dicting early technique failure is difficult due to the myriad
medical and social factors that may influence the outcome.
These factors may also have a non-linear relationship with
early technique failure and may be subject to complex vari-
able interactions.
Artificial neural networks (ANNs) are a relatively new
class of statistical prediction tools that are particularly
C   The Author [2008].
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Fig. 1. Artificial neural network (ANN) architecture. ANNs consist of
artificial neurons. Each artificial neuron has a processing node (‘body’)
represented by circles in the figure as well as connections from (‘den-
drites’) and connections to (‘axons’) other neurons which are represented
as arrows in the figure. In a commonly used ANN architecture, the mul-
tilayer perceptron, the neurons are arranged in layers. An ordered set
(a vector) of predictor variables is presented to the input layer. Each neu-
ronoftheinputlayerdistributesitsvaluetoalloftheneuronsinthemiddle
layer. Along each connection between input and middle neurons there is
a connection weight so that the middle neuron receives the product of the
value from the input neuron and the connection weight. Each neuron in
the middle layer takes the sum of its weighted inputs and then applies a
non-linear (usually logistic) function to the sum. The result of the function
then becomes the output from that particular middle neuron. Each middle
neuron is connected to the output neuron. Along each connection between
a middle neuron and the output neuron there is a connection weight. In
the final step, the output neuron takes the weighted sum of its inputs
and applies the non-linear function to the weighted sum. The result of this
functionbecomestheoutputfortheentireANN.Moredetailsareprovided
in the appendix.
suitedtocomplexpatternrecognitiontasks(Figure1andthe
appendix) [13]. ANNs have the advantage of automatically
detecting and modelling complex non-linear relationships
between ‘inputs’ to the network (i.e. patient demographic,
clinical and laboratory data) and the ‘output’ (i.e. early
technique failure) and can consider all possible interac-
tions between the input variables. In contrast, conventional,
regression-based, methods require non-linear relationships
between input and output variables to be specified ap r i o r i .
Interactions must be pre-specified in regression analyses
and relatively few of these can be accommodated [14,15].
ANNs have been used successfully as a prediction tool in
a variety of medical and non-medical situations [13]. In
nephrology, ANNs have been used successfully to screen
for glomerulopathy using urine biomarkers, to predict ery-
thropoeitin responsiveness, to stratify PD membrane char-
acteristicsandtopredictdelayedrenalallograftdysfunction
[16–25].
The United Kingdom Renal Registry (UKRR) is a large,
comprehensive, validated and prospective data source that
includes information from the majority of the ESRD pa-
tients in the United Kingdom [6]. In the current analysis,
we used data from the UKRR in order to determine the
predictive performance of ANN models and to compare
the ability of the ANN approach with a traditional logis-
tic regression (LR) model to predict early PD technique
failure.
Methods
Description of the data source
The UKRR is operated under the auspices of the UK Renal
Association and provides independent audit and analysis
of renal care in the UK. The UKRR data collection meth-
ods have been described in detail elsewhere [6]. In brief,
renal units using registry-compatible information systems
are required to electronically export data to the UKRR on a
quarterly basis. Local software extraction routines identify
allpatientsondialysisorwitharenaltransplantandgathera
predefineddatasetwhichincludessocio-demographicdata,
ESRD diagnosis, any modality changes during the cur-
rent quarter, date of death, transfers to other centres and
3-monthly recordings of weight, blood pressure and lab-
oratory parameters. Data arriving at the UKRR are sub-
ject to algorithms that identify incongruent values that are
then verified with the renal units and corrected if required.
Completeness of returns approaches 100% for primary
diagnosis-related information and >60% overall for other
data supplied by the renal units [6].
Data from 60 renal units servicing a population base of
53.4 million were included in the current analysis.
Subjects
The present analysis included all incident dialysis patients
older than the age of 18 in the UKRR who started PD
from 1 January 1999 until 31 December 2004. Patients
were considered to have selected PD as their initial dialysis
modality if they were receiving PD at 90 days after starting
renal replacement therapy.
Data abstraction
Data abstracted for each eligible subject included the dates
ofdialysisinitiation,transitiontohaemodialysis,transplan-
tation,losstofollow-upand/ordeath.Theprimaryoutcome
of interest was PD technique failure. Patients who died or
were lost to follow-up while on PD, received a renal trans-
plant or who remained on PD until 31 December 2004 were
defined as technique survivors. Technique failure was de-
fined as a change in dialysis modality to haemodialysis for
aperiodexceeding1month.Forpatientswhochangeddial-
ysis modality more than once, the starting date of the first
period of haemodialysis that lasted greater than 1 month
was considered to be the technique failure date. For each
subject, an end date was defined as the date of the earliest
event among the possible outcomes of remaining on PD
until 31 December 2004, technique failure, transplantation,
loss to follow-up or death. The observation time for each
subject was then calculated as the number of days between
dialysis initiation and the end date. The outcome variable,
‘PD technique failure’, was coded as ‘1’ if the end date
corresponded to technique failure and a ‘0’ for all other
outcome events. A Kaplan–Meier cumulative probability
curve for PD technique failure was plotted with SPSS ver-
sion 15.0, Chicago, IL, USA.
The subset of potential predictor variables abstracted
from the UKRR included demographic, clinical and2974 N. Tangri et al.
Table 1. Summary of the predictor variables included in the artificial neural network and logistic regression analyses for subjects who did not and who
did suffer peritoneal dialysis technique failure.
Technique survival Technique failure P-value
Variable Mean ± SD or % (N) Mean ± SD or % (N)
Observation time (days) 617 ± 494 (1811) 299 ± 344 (1458) <0.001∗
Demographics
Age (years) 60.9 ± 15.8 (1811) 55.8 ± 16 (1458) <0.001∗
Female sex 38.5 (1811) 38 (1458) 0.775
Caucasian race 91.1 (1383) 90.6 (1242) 0.641
Cause of ESRD
Diabetes 22.1 (1811) 18.2 (1458) 0.005
Glomerulopathy 12.1 (1811) 15.9 (1458) 0.002
Renovascular disease 12.9 (1811) 11.8 (1458) 0.355
PCKD 5.6 (1811) 7.6 (1458) 0.021
Pyelonephritis 6.5 (1811) 8 (1458) 0.088
Other 12.2 (1811) 12.1 (1458) 0.956
Unknown 28.7 (1811) 26.3 (1458) 0.139
Comorbid conditions
Sympt. CVD 11.5 (615) 8.3 (504) 0.072
Angina 24.1 (615) 15.5 (502) <0.001∗
Past MI 14.5 (615) 11.3 (504) 0.114
Past CABG 7.8 (614) 5.4 (504) 0.096
Angioplasty 4.9 (613) 2.8 (498) 0.069
PVD 3.1 (613) 2.2 (501) 0.346
Leg ulcer 4.9 (610) 3.6 (501) 0.272
Claudication 15.7 (613) 9.6 (500) 0.002
Smoking 20.5 (599) 18.8 (490) 0.467
COPD 7 (613) 5.1 (505) 0.190
Diabetes 10.3 (610) 10.6 (502) 0.901
Malignancy 9.5 (612) 9.5 (504) 0.979
Liver disease 1.6 (615) 2.2 (502) 0.495
Physical examination
Weight (kg) 69.8 ± 14.3 (497) 71.4 ± 14.6 (438) 0.091
Height (cm) 168 ± 10 (431) 169 ± 10 (386) 0.207
SysBP (mmHg) 141 ± 26 (819) 144 ± 25 (701) 0.051
DiasBP (mmHg) 79 ± 14.5 (819) 82.1 ± 14.1 (701) <0.001∗
Laboratory data
Calcc (mmol/L) 2.43 ± 0.21 (1685) 2.43 ± 0.21 (1380) 0.827
Phos (mmol/L) 1.59 ± 0.49 (1667) 1.61 ± 0.46 (1357) 0.159
Alb (g/L) 32 ± 6 (1701) 33.5 ± 5.1 (1376) <0.001∗
IPTH (pmol/L) 26 ± 28.3 (909) 25.6 ± 29.4 (789) 0.756
Creat (µmol/L) 608 ± 211 (1737) 664 ± 226 (1405) <0.001∗
Urea (mmol/L) 18.7 ± 7.2 (1727) 18.9 ± 6.4 (1397) 0.459
Haem (g/dL) 11.1 ± 1.7 (1715) 11 ± 1.7 (1377) 0.425
Ferritin (µg/L) 323 ± 497 (1387) 292 ± 377 (1182) 0.082
Cholesterol (mmol/L) 5.22 ± 1.28 (787) 5.3 ± 1.45 (629) 0.330
Bicarbonate (mmol/L) 26.3 ± 4.2 (1534) 26.1 ± 3.8 (1212) 0.112
HbA1c (%) 7.48 ± 1.86 (176) 7.51 ± 1.91 (164) 0.893
Aluminium (µmol/L) 0.318 ± 0.634 (305) 0.307 ± 0.47 (307) 0.804
Continuous variables are shown as means ± standard deviations (SD) while categorical variables are shown as percentages (%). The number of subjects
on which a mean value or percentage was calculated is given in the parentheses. Statistical significance was computed with independent t-tests for
continuous variables and chi-square tests for categorical variables. The nominal significance level of 0.05 was Bonferroni-adjusted for the numbero f
tests such that a P-value of 0.00125 or less (∗) was considered to be significant. For each subject, blood pressure values, weight and laboratory values
represent measurements closest to the date of peritoneal dialysis initiation while height values are the average of all available measurements.
ESRD = end-stage renal disease, CVD = cardiovascular disease, MI = myocardial infarction, CABG = coronary artery bypass grafting, PVD =
peripheral vascular disease, COPD = chronic obstructive pulmonary disease, SysBP = systolic blood pressure, DiasBP = diastolic blood pressure,
Calcc = calcium concentration adjusted for albumin, Phos = phosphate concentration, Alb = albumin concentration, iPTH = intact parathyroid
hormone concentration, Creat = creatinine concentration, Haem = haemoglobin concentration and HbA1c = haemoglobin A1c percentage.
laboratory variables (Table 1). The demographic variables
included the date of birth, and binary indicators of gender
and Caucasian race. The age at dialysis initiation was cal-
culated as the number of days between the dates of birth
and dialysis initiation divided by 365.25.
The clinical variables included the aetiology of ESRD
that was encoded as a set of mutually exclusive binary indi-
cators for diabetic nephropathy, glomerulonephritis, reno-
vascular disease, polycystic kidney disease, pyelonephritis,
other and unknown causes. The following binary indica-
tors of co-morbid illnesses were included in the analysis:
diabetes mellitus (excluding subjects already categorized
as having diabetic nephropathy), symptomatic cardiovas-
cular disease, angina pectoris, past myocardial infarction, a
history of coronary artery bypass surgery, a history of an-
gioplasty, peripheral vascular disease and/or non-traumaticPredicting technique survival in peritoneal dialysis patients 2975
lowerlimbamputation, lowerlimbulceration, claudication,
pastorpresentsmoking,chronicobstructivepulmonarydis-
ease, known malignancy and liver disease. Dialysis centre
was indicated by a set of mutually exclusive binary indica-
torsforeachrenalunitwithatleast20prevalentPDpatients
on 31 December 2004. Subjects belonging to centres with
fewer than 20 PD patients on that date were assigned a
generic binary centre indicator. Patients were assigned to
the dialysis unit where their PD was initiated regardless
of subsequent migration to another renal unit. A centre-
size variable was assigned to each subject that was equal
to the number of patients served by their assigned renal
unit on 31 December 2004. For patients who were assigned
the generic centre code, the sum of the patients served by
the units included in the generic code was employed as
their centre-size value. The measurements of systolic and
diastolic blood pressure and weight closest to the date of
dialysis initiation were chosen for inclusion in the analysis
while the value for height was the average of all available
measurements for each subject.
The quarterly laboratory data closest to the date of dial-
ysis initiation were included in the analysis. The laboratory
variables that were abstracted included the concentrations
of creatinine, urea, calcium, phosphate, intact parathyroid
hormone, bicarbonate, albumin, total cholesterol, ferritin
and haemoglobin (Table 1). Each calcium value was cor-
rected for albumin using the formula CorrCa = Ca +
[(40−Alb)×0.025].Clinicalandlaboratorydatawerecom-
pared between patients with technique survival and failure
using t-tests and chi-squared tests for continuous and cat-
egorical variables, respectively, using SPSS version 15.0,
Chicago, IL, USA.
Each laboratory variable was evaluated for normality
by visual inspection of histograms and by normal plots.
Skewed variables were transformed and re-evaluated for
normality: the ferritin level was transformed by the log10
function and the intact PTH and aluminium values were
transformed by the natural logarithm function. For binary
input variables, missing values were imputed by replacing
the value with the proportion of positive cases across all
subjects in whom the value of the binary variable was not
missing.Agivenmissingcontinuousinputvariablewasim-
puted with a multiple regression model such that the miss-
ing variable was considered as the dependent and the rest
of the continuous variables were considered as the indepen-
dent variables. For the purpose of missing data imputation,
a set of such regression models was created for each of the
continuous input variables.
ANN bootstrap procedure
Multilayer perceptron ANNs with 40-80-1 nodal architec-
tures were constructed and trained using the back propa-
gation approach with Neuroshell 2 version 3.0. (Ward Sys-
tems Group, Frederick, MD, USA). In order to enhance
ANN training, by eliminating inputs with the value ‘0’, all
input factors were transformed to values between 1 and 2
using the equation x  = [(x –m i n ( x))/(max(x)–m i n ( x))] +
1w heremin(x)andmax(x)aretheminimumandmaximum
of the input variable ‘x’ across all subjects.
The predictive performance of the application of the
ANN approach to the analysis of PD technique failure was
determined with a bootstrap approach [26]. For each of 20
bootstrap iterations, 75% of the data (∼2450 cases) were
randomly selected and used to train a network. The training
of the ANN was stopped when the average difference be-
tween the known outcome of the training cases (2 for event
and 1 for no event) and the predicted outcomes from the
ANN (numbers between 1 and 2) converged to a pre-set
minimum (see the appendix). The trained ANN was then
used to make predictions on a validation set consisting of
the remaining 25% of cases in the dataset. Twenty random
training and validation sets and ANNs were created in this
way.
The accuracy of the 20 sets of predictions was each as-
sessed by the area under the receiver operating character-
istic curve (AUROC). An AUROC of 1.0 implies perfect
discrimination between cases and controls in the validation
set while a value of 0.5 indicates no predictive ability. The
AUROC was computed using CLABROC software version
1.9.1 [27,28]. The 20 AUROC values and their standard
errors were then averaged.
Usingthe‘slope’parametersprovidedbytheCLABROC
software for each of the 20 validation sets, the optimum
thresholds for discriminating between patients with PD
technique success and failure were calculated (see the ap-
pendix) [29,30]. Using these thresholds, the resulting sen-
sitivity, specificity, positive predictive value and negative
predictive values were calculated for each bootstrap sam-
ple. In addition, the classification accuracy was calculated
for each sample as sum of the number of true positives and
true negatives divided by the total number of patients in the
validation set. For a given bootstrap sample, the improve-
ment in accuracy beyond that which would be expected by
chance was computed as the ratio of the observed classifi-
cation accuracy to the accuracy expected by chance.
Logistic regression bootstrap procedure
For the LR analyses, the outcome of interest was the devel-
opment of technique failure within 1 year of starting PD.
Patients who were observed for a period shorter than 1 year
and who were censored (functioning PD on 31 Decem-
ber 2004, death or loss to follow-up with functioning PD or
transplant)wereexcludedfromtheLRanalyses(704/3269).
The data transformation that converted inputs and outputs
to a range between 1 and 2 for the ANN training and vali-
dation was not undertaken for the LR analyses.
Otherwise, a similar strategy was employed for the LR
bootstrap. Twenty random samples consisting of 75% of
the cases were each used to derive a LR model. Each of
the 20 models incorporated all the potential predictor vari-
ables that were used to train the ANNs without any in-
teraction terms. For each of the 20 regression equations,
the intercept parameter and model coefficients were then
used to make predictions on the remaining 25% of cases
in the dataset. Twenty random ‘training’ and validation sets
and LR models were created in this way. The average AU-
ROC statistic and its standard error were computed as de-
scribedabove.Likewise,thesensitivity,specificity,positive2976 N. Tangri et al.
Fig. 2. The Kaplan–Meier curve for probability of peritoneal dialysis (PD) technique failure after the initiation of PD. Survival until 31 December
2004, death, transplantation or loss to follow-up with functioning PD were considered to be censored observations.
predictivevalueandnegativepredictivevalues,andtheclas-
sification accuracy were calculated as described above.
Comparison of the ANN and logistic models
The 20 ROC curves from the ANN bootstrap were com-
pared with the 20 from the logistic bootstrap that yielded
400 paired comparisons. For each comparison, the ratio of
the difference in the areas of the ANN and logistic ROC
curves to the standard error of the difference yielded a nor-
mally distributed z-statistic and a two-sided P value [31].
The overall significance of the difference in AUROC for
the ANN and logistic bootstrap samples was taken as the
average of the P values for the 400 pairs.
Results
Patient characteristics
A Kaplan–Meier plot of the cumulative probability of PD
techniquefailureasafunctionoftimesincetheinitiationof
PD is shown in Figure 2. Baseline demographic and labora-
tory characteristics of the patients are presented in Table 1.
The mean age of the patients was 59.9 years. Technique
survivors were, on average, 5 years older than patients who
suffered technique failure (P < 0.001). The majority of the
patients were Caucasian and 38% were female. The mean
observation time was 430 days. Forty-five percent of the
patients suffered from technique failure during the obser-
vation period. Patients who failed PD had higher values
for diastolic blood pressure, serum creatinine and albu-
min (all P values < 0.001). Subjects who suffered from
PD technique failure were less likely to have had a previ-
ous myocardial infarction (P < 0.001). After Bonferroni
correction for multiple testing, there were no other signifi-
cant differences between the predictor variables in the two
groups of patients.
ANN bootstrap results
The results for the bootstrap iterations are shown in
Table 2. The average AUROC and standard error of the
AUROC were 0.760 and 0.0167, respectively. Each AU-
ROC calculation using the CLABROC software yielded
two parameters, which, when averaged over the 20 sam-
ples, allowed for the construction of an average receiver
operating characteristic curve as shown in Figure 3. One of
the20validationsetswaschosenatrandominordertocon-
struct a histogram comparing the ANN outputs for patients
who suffered from technique failure versus those who did
not (Figure 4). The average of the optimal thresholds was
1.46 that yielded average sensitivity, specificity, positive
predictive value and negative predictive value of 70, 68, 64
and74%,respectively.Usingtheoptimumthresholdtheav-
erage classification accuracy in the validation set was 69%
whereas the expected accuracy by chance was 51%. This
represents a 37% improvement in classification accuracy
beyond chance (P < 0.0001).
Logistic regression bootstrap results
The results for the logistic bootstrap iterations are shown
in Table 2. The average AUROC and standard error of thePredicting technique survival in peritoneal dialysis patients 2977
Table 2. Mean predictive performance for 20 artificial neural network
(ANN) models and logistic regression models created using a bootstrap
approach.
Model Artificial neural Logistic
network regression
AUROC 0.7602 0.7090∗
Standard error 0.0167 0.0208
Optimal threshold 1.4627 0.4016
Sensitivity 0.7043 0.6021
Specificity 0.6818 0.6856
Positive predictive value 0.6392 0.5469
Negative predictive value 0.7421 0.7320
IABC 1.3655 1.2411
∗P = 0.016.
AUroc = area under the receiver operating characteristic curve (a value
of 1.0 implies perfect discrimination between PD technique failure
and success whereas 0.5 implies no discrimination); Optimal threshold.
= the optimal threshold ANN output value that maximizes sensitivity and
specificity; IABC = improvement in accuracy beyond chance (the ratio
of the observed number of true positive plus true negative cases at the
optimal threshold to the number expected by chance).
Fig. 3. Receiver-operating characteristic (ROC) curves for the artificial
neural network (ANN) and logistic regression bootstrap analyses (see the
text for a description of the bootstrap procedure). The curves represent the
average curves for the 20 ANN and 20 logistic models. The area under
the ROC curve (AUROC) is an index of predictive performance: an AU-
ROCof1.0representsperfectdiscriminationwhileavalueof0.5indicates
nodiscriminationbetweensubjectswithandwithoutPDtechniquefailure.
The average AUROC values for the ANN and logistic regression models
were 0.760 and 0.709, respectively (P = 0.0164).
AUROC were 0.709 and 0.0208, respectively. As described
above, the average receiver operating characteristic curve
is shown in Figure 3. A histogram of the distribution of the
predictions for a randomly selected LR model for subjects
who actually did and did not suffer from technique failure
in the first year of PD is shown in Figure 5. For the logis-
tic models, the average of the optimal thresholds was 0.40
that yielded average sensitivity, specificity, positive predic-
tive value and negative predictive value of 60, 68, 55 and
74%, respectively. Using the optimum threshold the aver-
age classification accuracy in the validation set was 65%
whereas the expected accuracy by chance was 53%. This
Fig. 4. Histogram of the artificial neural network (ANN) model output
whenappliedtothevalidationsetforsubjectswhodidanddidnotsufferPD
techniquefailure.Foreachof20bootstrapsamples,thedatawererandomly
divided into a training set from which an ANN model was derived, and
a validation set on which the ANN was validated. The histogram data
representoneofthe20setsofvalidationsetpredictionsselectedatrandom.
Fig. 5. Histogram of the logistic regression model output when applied
to the validation set for subjects who did and did not suffer PD technique
failure. For each of 20 bootstrap samples, the data were randomly divided
into a ‘training set’ from which a regression model was derived, and a
validationsetonwhichtheregressionmodelwasvalidated.Thehistogram
data represent one of the 20 sets of validation set predictions selected at
random.
represents a 24% improvement in classification accuracy
beyond chance (P < 0.0001).
Comparison of the ANN and logistic regression models
Overall,theANNmodelsperformedbetterthanthelogistic
ones. The average difference in the AUROC values for the
ANN and LR models was 0.0512 (Figure 3, Table 2). In
order to put this gain into perspective, consider that the
maximum possible improvement in predictive performance
for the average ANN model would be 1−0.709 = 0.291.
Thus the observed gain in performance represents 17.6%2978 N. Tangri et al.
of the theoretical maximum. The P value averaged over all
400 possible comparisons between ANN and logistic ROC
curves was 0.0164.
Discussion
In the United Kingdom, 24% of patients starting renal
replacement therapy choose PD as their initial treatment
modality [6], with PD being twice as common in patients
who are under the age of 65 compared with those who are
older.EarlytechniquefailurewithPDremainsasignificant
problem in the United Kingdom ESRD population. In the
cohort of patients who were included in the present study,
45% developed technique failure over a mean observation
period of 430 days. This high rate is consistent with data
from other large renal registries [10,11]. Thus, early tech-
nique failure is a major impediment to the growth of PD
as a treatment option globally. The premise underlying the
currentstudywasthattheaccurateidentificationofpatients
at particularly high risk of early technique failure at the ini-
tiation of PD would allow for greater clinical scrutiny and
timely intervention in order to forestall the outcome.
Previous investigators have used regression methods in
order to identify factors that influence PD technique sur-
vival in groups of patients. For example, McDonald et al.
found a significant relationship between body-mass index
and early technique failure using data from the ANZDATA
registry in Australia and New Zealand [10]. Likewise,
Tonelli found that aboriginal ethnicity had a significant,
independent effect on PD mortality and technique survival
in Canada [9]. Huisman et al. studied the impact of centre
effect using data from the Dutch renal registry and found
that the number of PD patients treated in a renal unit was
inversely related to the probability of early technique fail-
ure [11]. Although these investigations have provided very
important contributions to our understanding of the nature
of early PD technique failure, they were not designed with
the goal of predicting the likelihood of this outcome for
individual patients.
The UKRR presents a unique opportunity for the de-
velopment of predictive models. The registry is a large
repository of data that is subject to stringent quality con-
trol [6]. The automated and electronic submission from the
participating renal units ensures that information regarding
all patients receiving renal replacement therapy is captured
prospectively. We hypothesized that the combination of the
high-quality data contained in the UKRR combined with a
sophisticatedpredictionmethod,theANN(Figure1andthe
appendix),wouldbeabletopredictearlyPDtechniquefail-
ure accurately. Furthermore, a secondary hypothesis was
that the ANN method would perform better than a tradi-
tional, LR-based prediction model.
We found that application of an ANN to the UKRR
dataset predicted PD technique survival with moderate ac-
curacy (AUROC 0.760). This can be understood intuitively
to mean that, given two patients, one who ultimately will
suffer PD technique failure and one who will not, our av-
erage ANN model will produce a higher score for the for-
mer patient 76% of the time [32,33]. If one were to use
the optimal threshold, a clinically and statistically signifi-
cantimprovementinclassificationaccuracybeyondthatex-
pected by chance would be observed. The average AUROC
value observed in the current study compares favourably
with previous ANN-based prediction models in medical
applications such as predicting psychosis outcomes, pre-
dicting response to chemotherapy and classifying tumours
(AUROCs 0.70–0.91) [13,34,35]. In nephrologic applica-
tions, such as screening for glomerulopathy using urine
biomarkers,predictingerythropoeitinresponsiveness,strat-
ifying PD membrane characteristics and predicting delayed
renal allograft dysfunction, AUROC values ranged from
0.65 to 0.95 and sensitivities and specificities ranged from
64 to 92% and 65 to 92%, respectively [16–25].
ANNshavedistinctadvantagescomparedtothemorefa-
miliarLRmodels.Logisticmodelsassumelinearbehaviour
which means that as the value of a given predictor variable
increases,thepredictedriskoftheoutcomeincreases.How-
ever, non-linear, ‘U-shaped’, relationships between predic-
tor variables and outcome risk have been noted in other
areas of nephrology such as the effect of serum biochem-
ical markers–urea, potassium, bicarbonate, phosphate, and
cholesterol–on the mortality risk of haemodialysis patients
[36–38]. Logistic models can accommodate non-linear be-
haviour by first transforming the variable using a logarith-
mic or polynomial function, but the analyst must know
ap r i o r ithat the non-linearity exists and also which trans-
forming function to apply.
In general, ANN-based prediction models have outper-
formed LR-based ones in medical applications [13]. For
example, Green et al. found that ANNs were superior
to LR in the prediction of acute myocardial infarction
(AUROC values: ANN = 0.811, LR = 0.764, P = 0.03)
[34]. Studies that have assessed the performance of logistic
modelsinotherareasofnephrology—suchaspredictingthe
progression to ESRD among patents with chronic kidney
disease—have yielded disappointing results. For example,
Hemmelgran et al. applied a regression model to a cohort
of 10 184 elderly patients to predict rapid progression of
CKD and found an AUROC of 0.59 in their validation set
[39]. The results of the present study are consistent with
this theme: we found the ANN approach to be superior to
an LR approach for the outcome of PD technique survival
(AUROC 0.760 versus 0.709, P = 0.0146). Comparing the
distributionsofmodeloutputs(Figures4and5),thelogistic
predictions did not discriminate between subjects who did
and did not suffer technique failure as cleanly as the ANN
predictions did.
The current study has limitations. There was an inherent
bias in the selection of the study cohort since the subjects
had already chosen PD as a modality. This may limit the
ability to apply the prediction models to pre-dialysis pa-
tients who may be considering all forms of renal replace-
ment therapy. The UKRR is a superb data source; however,
somevaluesweremissingforthepredictorvariablesusedin
the study. For example, only about one-third of the subjects
had information regarding co-morbid illnesses. The ANN
and logistic models lacked information on residual renal
function and peritoneal membrane fluid and solute clear-
ancecharacteristicsthatmayhaveimprovedtheirpredictive
ability[8].Informationregardingtheaetiologyoftechnique
failure was also not available. The predictive performancePredicting technique survival in peritoneal dialysis patients 2979
may have been improved by the use of a more refined out-
come, that is knowledge of not only when PD technique
failure occurred but why. However, the fact that the ANN
models were able to achieve a respectable performance
despite these data limitations provides a basis for optimism
that, when such data become available in the UKRR, the
performance of future models will improve substantially.
Whether or not the performance of the ANN models
improves, there are some practical issues regarding their
implementation in a PD clinic. The ANN models included
observation time as an input variable. This would seem to
precludetheuseoftheANNapproachintheclinicsincethe
observation time for a given incident PD patient cannot be
known ap r i o r i . However, this is not really an issue because
a fixed time could be selected (such as 1, 2 or 5 years) and
entered as an input to the trained ANN in order to produce
predictionsforthattimehorizon.Anotherpotentialconcern
is that, unlike LR-based prediction models, the output from
an ANN is not a probability per se, but, rather, a risk score.
To make the output of an ANN model comprehensible to
health care providers and patients, it would have to be re-
calibrated as a probability value. However, even in its raw
form, the output of an ANN could be used, along with a
threshold value, to help clinicians to make a dichotomous
decision regarding whether a given patient should receive
extra clinical scrutiny or not. LR models, in theory, can
be used to calculate the probability of an outcome with a
handheld calculator while ANN prediction models must be
implemented on a computer. Given that the provision of
modern PD care is computationally advanced, with com-
puterized modelling of dialysis prescription for example,
the addition of another computer-based tool should not be
overly burdensome.
In conclusion, an ANN-based model performed reason-
ably well in predicting early technique failure among in-
cident PD patients. The ANN performed significantly bet-
ter than a traditional, LR-based prediction model. As the
UKRR repository grows, interms of the number of patients
captured and the detail of the data, whether even more so-
phisticated ANN technology will provide better predictive
performance will remain as an area of active investigation.
Appendix
ANN fundamentals
ANNs are implemented as software programs that simu-
late the information processing architecture of a network
of biological neurons. Each artificial neuron consists of an
informationprocessingnode (‘body’),itsconnections from
other neurons (‘dendrites’) and its connection to other neu-
rons(‘axons’).AtypicalANNconsistsoflayersofartificial
neurons. In the most common arrangement, the multilayer
perceptron (MLP) (Figure 1), a set of input neurons each
receivesoneofthevaluesofanorderedset(avector)ofpre-
dictor variables. Information from the predictor variables is
passed through the layers of the ANN such that, between
layers, a set of weight factors modifies the information.
The neurons within a layer each sum the weighted inputs
from their ‘dendrites’ and then apply a non-linear function
(usually the logistic) to the sum that is sent out as an output
along their ‘axons’. Ultimately, the modified information
reaches the output neuron that performs a final summa-
tion and non-linear function application. The result of this
function becomes the output for the entire ANN (Figure 1).
In order for an ANN to be useful, it must be trained.
Training involves presenting a set of cases that each have
values for the predictor variables as well as a known out-
come [e.g. PD technique failure (outcome = 1) versus no
failure(outcome=0)].Initially,theweightsinsidetheANN
are set to random values so that its output is meaningless.
However, with each case that is presented to the ANN, an
error value, which is the difference between its output and
the actual outcome (1 or 0), is used to adjust the weights
within the ANN so as to minimize the error on subsequent
presentations. The procedure for adjusting the weight val-
ues is known as the generalized delta rule [40]. The error
signals are propagated backwards layer-by-layer through
the ANN and, hence, this training approach is known as
back-propagation. Each neuron in the middle layer receives
the error value from the output neuron multiplied by the
weight connecting the neurons. The modified error values
for the neurons in the middle layer are then used to com-
pute the error terms for the neurons in the input layer. Each
input neuron takes a weighted sum of the error values of
the neurons to which it connects in the middle layer. The
weights used in this calculation are the same connection
weights between the two layers that were used to generate
the output.
After the error value has backpropagated, the weights
are adjusted using the following formula:  wij =
α∗ei
∗[o∗(1−o)] where ‘ wij’ is the weight change for the
connection between the ithneuron inthe input layer and the
jth neuron in the middle layer, ‘α’ is the learning rate coef-
ficient (which determines the fraction of a weight change
thatisproducedbyagivenerrorvalue)and‘o’isthecurrent
value of the ANN output. Likewise, the weights connecting
the middle layer and the output neuron are adjusted. After
eachsetof‘n’inputvectorsandknownoutputsispresented
to the ANN, an overall error measure is calculated such as
the mean square error, MSE = (1/n) (tk−ok)2 where ‘tk’
is the actual value for associated with the kth input vector
and ‘ok’ is the ANN output for that vector. Eventually, after
many presentations of the set of training vectors, the MSE
value converges to a minimum. At this point the ANN has
been trained and is ready to make predictions on a new set
ofcases.InordertovalidatetheperformanceoftheANN,it
is tested against new cases with known outcomes (the vali-
dation set) and a performance statistic such as the AUROC
is computed.
Optimal threshold values for ROC curves
Building on the work of previous authors [30,41–43], it is
possible to generate a closed form equation for the optimal
threshold of an ROC curve [29]. Let x represent the pos-
sible values of the output from a prediction model (ANN
or LR) when applied to a validation set. Assume that x is
distributed as two Gaussian distributions: xD ∼N(µD,σD)
and xN ∼N(µN,σN) for individuals with and without PD
technique failure, respectively. The optimal threshold, xt,2980 N. Tangri et al.
is the value for x which maximizes y = sens(x)+spec(x)
where the sensitivity and specificity at xt are sens(xt) =
Prob(x≥xt ; µD,σD) = 1− [(xt – µD)/σD] and spec(xt) =
Prob(x≤xt | µN,σN) =  [(xt – µN)/σN], respectively and
where  [g] is the standard normal probability mass func-
tion at ‘g’. Setting the first derivative of y with respect to xt
to 0 and solving for xt yields xt = (bµD + µN)/(1+b) where
b = (σN/σD). An estimate for ‘b’ is provided by CLABROC
[28] while µD and µN can be estimated from the average
outputs of the subjects with and without PD technique fail-
ure, respectively, in the validation set.
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